To the Editor:
Cognitive impairment, including dementia, affects up to 70% of individuals receiving maintenance hemodialysis,1 a prevalence that exceeds that of the elderly general population by 3- to 7-fold.2 Cardiometabolic risk factors for dementia, such as diabetes, hypercholesterolemia, hypertension, and vascular disease, are highly prevalent in end-stage kidney disease.3 However, the rate of new-onset dementia is higher among hemodialysis patients compared with peritoneal dialysis patients,4 suggesting that aspects of the hemodialysis procedure may contribute to the development of dementia.
Imaging studies show that hemodialysis can cause significant circulatory stress via ultrafiltration-induced hypoperfusion of vital vascular beds, including the brain.5 Maintenance of adequate cerebral perfusion during dialysis is dependent on intradialytic blood pressure and the brain’s intrinsic ability to preserve relatively constant blood flow despite changes in perfusion pressure. Hemodialysis patients may be particularly susceptible to the neurologic consequences of dialysis-induced blood pressure declines due, in part, to diminished autoregulatory capacity from autonomic and endothelial dysfunction.6, 7 It is thus plausible that repeated exposure to intradialytic hypotension (IDH) and associated cerebral hypoperfusion may increase dementia risk. In fact, general population data indicate that orthostatic hypotension8 as well as cerebral hypoperfusion9 are associated with accelerated cognitive decline and a higher risk of new-onset dementia. Although a recent study found an association between IDH and reversible cognitive decline in the immediate post-dialysis period,10 the relationship between long-term, cumulative IDH exposure and the development of dementia in the hemodialysis population has not been established.
The objective of our study was to examine the association between the cumulative exposure to frequent IDH and the 5-year risk of new-onset dementia among elderly individuals initiating maintenance hemodialysis at a large U.S. dialysis organization. After a 30-day lag period following hemodialysis initiation, we determined if patients experienced frequent IDH in successive 90-day exposure intervals (Supplementary Figure S1). Within a given exposure interval, we classified an individual as having frequent IDH if he or she experienced a nadir intradialytic systolic blood pressure <90 mm Hg in at least 30% of hemodialysis treatments. This IDH definition has been associated with all-cause mortality, an important competing event in our analysis.11 We evaluated the association between the time-updated, cumulative number of exposure intervals with frequent IDH after dialysis initiation and new-onset dementia using marginal structural Fine and Gray proportional subdistribution hazards models. All-cause death was treated as a competing event.
A total of 31,055 individuals initiated maintenance hemodialysis from June 1, 2005, to October 1, 2013, and met study selection criteria (Supplementary Table S1). The study cohort had an average age of 76.0 ± 6.6 years, 46.2% were women, 19.9% were black, 8.7% were Hispanic, and the most common cause of end-stage kidney disease was diabetes (43.7%). Baseline cardiovascular comorbid conditions were common: 39.9% of the cohort had an arrhythmia or conduction disorder, 59.2% had heart failure, 56.0% had ischemic heart disease, 29.1% had peripheral arterial disease and 18.8% had a history of stroke (Table 1 and Supplementary Table S2).
Table 1.
Characteristic | Total study population (N = 31,055) |
---|---|
Age at dialysis initiation, yr | 76.0 ± 6.6 |
Female | 14,359 (46.2) |
Race | |
Black | 6179 (19.9) |
White | 23,356 (75.2) |
Other | 1520 (4.9) |
Hispanic | 2705 (8.7) |
Cause of end-stage kidney disease | |
Diabetes | 13,565 (43.7) |
Hypertension | 11,636 (37.5) |
Glomerular disease | 1742 (5.6) |
Other | 4112 (13.2) |
Current smoker at dialysis initiation | 1090 (3.5) |
Inpatient dialysis initiation | 13,054 (42.0) |
Vascular access | |
Catheter | 22,398 (72.1) |
Fistula | 6580 (21.2) |
Graft | 2077 (6.7) |
Arrhythmia or conduction disorder | 12,393 (39.9) |
Diabetes | 20,379 (65.6) |
Dyslipidemia | 9972 (32.1) |
Heart failure | 18,370 (59.2) |
Ischemic heart disease | 17,398 (56.0) |
Peripheral arterial disease | 9046 (29.1) |
Stroke | 5834 (18.8) |
Valvular disease | 2464 (7.9) |
Pre-dialysis systolic blood pressure, mm Hg | |
≤130 | 8475 (27.3) |
131–150 | 12,240 (39.4) |
151–170 | 7736 (24.9) |
≥171 | 2604 (8.4) |
Values are given as number (percent) for categorical variables and as mean ± SD for continuous variables. Baseline covariates, including demographics, comorbid conditions, and health care utilization metrics were obtained in the 365 days preceding dialysis initiation. Baseline laboratory and dialysis treatment-related covariates were obtained in the 30 days immediately after dialysis initiation. The complete list of study cohort baseline characteristics is displayed in Supplementary Table S2.
The cohort was followed for a total of 64,982 person-years and had an average follow-up duration of 2.1 ± 1.6 years. During the 5-year follow-up period, 4991 individuals developed all-cause dementia (incidence rate = 7.7 cases of new-onset dementia/100 person-years) and 11,037 individuals died (incidence rate = 17.0 deaths/100 person-years). Greater cumulative exposure to frequent IDH after hemodialysis initiation was incrementally associated with a higher 5-year risk of new-onset dementia (Figure 1). Individuals who experienced frequent IDH in ≥ 7 (vs. zero) 90-day exposure intervals across time had the highest 5-year risk of new-onset dementia (hazard ratio [95% confidence interval] = 1.36 [1.20–1.48]).
We provide initial evidence linking cumulative IDH exposure to new-onset dementia among individuals receiving maintenance hemodialysis. Prior mechanistic studies have shown that hemodialysis-induced circulatory stress may contribute to the development of cerebral ischemic injury, but these studies were not powered to consider clinical outcomes. For example, in a cross-sectional study of 12 elderly hemodialysis patients from the Netherlands, Polinder-Bos et al.5 demonstrated that hemodialysis induces a significant reduction in global and regional cerebral blood flow. In a pilot study of 58 prevalent hemodialysis patients from the United Kingdom, MacEwen et al.12 found that more pronounced declines in intradialytic mean arterial pressure associated with a higher incidence of intradialytic cerebral ischemic episodes. Furthermore, in a prospective cohort study of 32 nondiabetic, Japanese hemodialysis patients, Mizumasa et al.13 noted that the number of IDH episodes (defined as a fall in systolic blood pressure >50 mm Hg within 30 minutes of starting hemodialysis plus associated symptoms of hypoperfusion) across time was weakly correlated with greater cerebral frontal lobe atrophy.
Our findings extend this mechanistic evidence by linking frequent IDH to the clinical outcome of new-onset dementia. Dementia is associated with a range of adverse outcomes, including lower quality of life14 and treatment nonadherence,15 as well as higher hospitalization and mortality rates.16, 17 Therefore, identification of effective interventions that reduce dementia risk is needed to improve patient outcomes. One promising hemodialysis-based intervention may be the use of cooled dialysate. Cooled dialysate reduces intradialytic hemodynamic instability,18 likely via cold-induced vasoconstriction and associated improvements in systemic vascular resistance during ultrafiltration. In a randomized controlled trial of 73 incident hemodialysis patients from the United Kingdom, Eldehni et al.19 found that hemodialysis with cooled dialysate (0.5°C below core body temperature) versus standard temperature dialysate (37°C) led to preservation of brain white matter microstructure at 1 year. This relatively low-risk intervention may be a viable, low-cost neuroprotective treatment strategy for individuals initiating hemodialysis. Other potential IDH reduction strategies include treatment time extension, more frequent dialysis, and ultrafiltration profiling, but supporting data, particularly with regard to the latter, are limited.
In conclusion, we found that increased cumulative exposure to frequent IDH after dialysis initiation was incrementally associated with a higher 5-year risk of new-onset dementia in a cohort of more than 30,000 elderly hemodialysis patients. Interventional studies are needed to determine if IDH mitigation reduces dementia risk among individuals receiving maintenance hemodialysis.
Disclosure
MMA and JEF received investigator-initiated research funding from the Renal Research Institute, a subsidiary of Fresenius Medical Care, North America. JEF received speaking honoraria from American Renal Associates, American Society of Nephrology, Dialysis Clinic, Incorporated, National Kidney Foundation, and multiple universities; consulting fees from Fresenius Medical Care, North America; and serves on the medical advisory board to NxStage Medical. LW declared no competing interests.
Acknowledgments
JEF is supported by grant K23 DK109401 awarded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health. Some of the data reported here have been supplied by DaVita Clinical Research, Inc., and were statistically de-identified. DaVita Clinical Research, Inc. had no role in the design or implementation of this study, or the in the decision to publish. In addition, some of the data reported here have been provided by the U.S. Renal Data System. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the U.S. government.
Footnotes
Study Methods.
Figure S1. Study design.
Table S1. Study inclusion and exclusion criteria.
Table S2. Complete list of study cohort baseline characteristics.
Table S3. Outcome and competing event definitions.
Table S4. Baseline and time-updated covariates.
Supplementary References.
Supplementary material is linked to the online version of the paper at www.kireports.org.
Supplementary Material
References
- 1.Murray A.M. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis. 2008;15:123–132. doi: 10.1053/j.ackd.2008.01.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Langa K.M., Larson E.B., Crimmins E.M. A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med. 2017;177:51–58. doi: 10.1001/jamainternmed.2016.6807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Longenecker J.C., Coresh J., Powe N.R. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol. 2002;13:1918–1927. doi: 10.1097/01.asn.0000019641.41496.1e. [DOI] [PubMed] [Google Scholar]
- 4.Wolfgram D.F., Szabo A., Murray A.M., Whittle J. Risk of dementia in peritoneal dialysis patients compared with hemodialysis patients. Perit Dial Int. 2015;35:189–198. doi: 10.3747/pdi.2014.00213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Polinder-Bos H.A., Garcia D.V., Kuipers J. Hemodialysis induces an acute decline in cerebral blood flow in elderly patients. J Am Soc Nephrol. 2018;29:1317–1325. doi: 10.1681/ASN.2017101088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Chesterton L.J., Sigrist M.K., Bennett T. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol Dial Transplant. 2005;20:1140–1147. doi: 10.1093/ndt/gfh808. [DOI] [PubMed] [Google Scholar]
- 7.Schiffrin E.L., Lipman M.L., Mann J.F. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007;116:85–97. doi: 10.1161/CIRCULATIONAHA.106.678342. [DOI] [PubMed] [Google Scholar]
- 8.Wolters F.J., Mattace-Raso F.U., Koudstaal P.J. Heart Brain Connection Collaborative Research Group. Orthostatic hypotension and the long-term risk of dementia: a population-based study. PLoS Med. 2016;13(10):e1002143. doi: 10.1371/journal.pmed.1002143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Wolters F.J., Zonneveld H.I., Hofman A. Cerebral perfusion and the risk of dementia: a population-based study. Circulation. 2017;136:719–728. doi: 10.1161/CIRCULATIONAHA.117.027448. [DOI] [PubMed] [Google Scholar]
- 10.Costa A.S., Tiffin-Richards F.E., Holschbach B. Clinical predictors of individual cognitive fluctuations in patients undergoing hemodialysis. Am J Kidney Dis. 2014;64:434–442. doi: 10.1053/j.ajkd.2014.02.012. [DOI] [PubMed] [Google Scholar]
- 11.Flythe J.E., Xue H., Lynch K.E. Association of mortality risk with various definitions of intradialytic hypotension. J Am Soc Nephrol. 2015;26:724–734. doi: 10.1681/ASN.2014020222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.MacEwen C., Sutherland S., Daly J. Relationship between hypotension and cerebral ischemia during hemodialysis. J Am Soc Nephrol. 2017;28:2511–2520. doi: 10.1681/ASN.2016060704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mizumasa T., Hirakata H., Yoshimitsu T. Dialysis-related hypotension as a cause of progressive frontal lobe atrophy in chronic hemodialysis patients: a 3-year prospective study. Nephron Clin Pract. 2004;97:c23–c30. doi: 10.1159/000077592. [DOI] [PubMed] [Google Scholar]
- 14.Tyrrell J., Paturel L., Cadec B. Older patients undergoing dialysis treatment: cognitive functioning, depressive mood and health-related quality of life. Aging Ment Health. 2005;9:374–379. doi: 10.1080/13607860500089518. [DOI] [PubMed] [Google Scholar]
- 15.Hain D.J. Cognitive function and adherence of older adults undergoing hemodialysis. Nephrol Nurs J. 2008;35:23–29. [PubMed] [Google Scholar]
- 16.Mapes D.L., Lopes A.A., Satayathum S. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS) Kidney Int. 2003;64:339–349. doi: 10.1046/j.1523-1755.2003.00072.x. [DOI] [PubMed] [Google Scholar]
- 17.McAdams-DeMarco M.A., Daubresse M., Bae S. Dementia, Alzheimer's disease, and mortality after hemodialysis initiation. Clin J Am Soc Nephrol. 2018;13:1339–1347. doi: 10.2215/CJN.10150917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Selby N.M., McIntyre C.W. A systematic review of the clinical effects of reducing dialysate fluid temperature. Nephrol Dial Transplant. 2006;21:1883–1898. doi: 10.1093/ndt/gfl126. [DOI] [PubMed] [Google Scholar]
- 19.Eldehni M.T., Odudu A., McIntyre C.W. Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol. 2015;26:957–965. doi: 10.1681/ASN.2013101086. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.